Clinical significance of CDKN2A homozygous deletion in combination with methylated MGMT status for IDH‐wildtype glioblastoma

OBJECTIVE: Accumulating evidence from recent molecular diagnostic studies has indicated the prognostic significance of various genetic markers for patients with glioblastoma (GBM). To evaluate the impact of such genetic markers on prognosis, we retrospectively analyzed the outcomes of patients with...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Cancer Med
Autori principali: Funakoshi, Yusuke, Hata, Nobuhiro, Takigawa, Kosuke, Arita, Hideyuki, Kuga, Daisuke, Hatae, Ryusuke, Sangatsuda, Yuhei, Fujioka, Yutaka, Sako, Aki, Umehara, Toru, Yoshitake, Tadamasa, Togao, Osamu, Hiwatashi, Akio, Yoshimoto, Koji, Iwaki, Toru, Mizoguchi, Masahiro
Natura: Artigo
Lingua:Inglês
Pubblicazione: John Wiley and Sons Inc. 2021
Soggetti:
Clinical Cancer Research
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC8124111/
https://ncbi.nlm.nih.gov/pubmed/33838014
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cam4.3860
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi